IDx Logo and Name Traditional Centered high res BRI Network
See the latest PT Akbar Indo Makmur Stimec Tbk stock price (AIMS:XIDX), related news, valuation, dividends and more to help you make your investing decisions.
OiS04OQCYnnmpW7rD967fXXeqlMbp3xfgdkrJm2Dch2Oyq1MaWNz9smmS7ynTmHB2ee0uK4Q=s900ckc0x00ffffff
AIMS fundamentals. Overview Statements Statistics Dividends Earnings Revenue More. AKBAR INDO MAKMUR STIMEC financial statements, including revenue, expenses, profit, and loss. The annual and quarterly earnings report below will help you understand the performance of AIMS. Q1 '22. Q2 '22. Q3 '22. Q4 '22.
ID Experts and our award winning platform are now IDX! IDX
Saham AIMS Akbar Indo Makmur Stimec Tbk (Informasi Harga, Grafik, Analisis Performa Perdagangan Saham)
IDX expects slowdown in transactions Markets The Jakarta Post
athenaIDX™ a new name for a powerful RCM solution athenahealth is proud to welcome athenaIDX to its family of revenue cycle management products. athenaIDX (formerly Centricity Business™ *) is an
Chart dan Harga Saham AIMS — IDXAIMS — TradingView
AKBAR INDO MAKMUR STIMEC annual and quarterly cash flow statement. View AIMS operating, investing, and financing activities.
Meet Project IDX Google's AIPowered, CloudBased IDE
Akbar Indo Makmur Stimec Tbk PT (IDX:AIMS) Intrinsic Valuation. Check if AIMS is overvalued or undervalued under the bear, base, and bull scenarios of the company's future.
Google Launches Project IDX AIPowered App Development Tool
By enabling diagnostic assessment in primary care settings, IDx aims to increase patient access to high-quality, affordable disease detection. The company's first product, LumineticsCore (formerly known as IDx-DR), is an FDA-cleared AI-based diagnostic system designed for use at the front lines of care to detect diabetic retinopathy.
AKBAR INDO MAKMUR STIMEC Trade Ideas — IDXAIMS — TradingView
By enabling diagnostic assessment in primary care settings, IDx aims to increase patient access to high-quality, affordable disease detection. The company's first product, LumineticsCore (formerly known as IDx-DR), is an FDA-cleared AI-based diagnostic system designed for use at the front lines of care to detect diabetic retinopathy.
IDx is the only company named to CB Insights Digital Health 150 with an FDAcleared autonomous
By enabling diagnostic assessment in primary care settings, IDx aims to increase patient access to high-quality, affordable disease detection. The company's first product, IDx-DR, is an FDA.
IDX Investor AIMS Q3 2019 PT Akbar Indo Makmur Stimec Tbk Analisis Laporan Keuangan
Get the latest Akbar IndoMakmur Stimec Tbk PT (AIMS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
ID Theft Software, Privacy & Identity Protection Technology IDX
About. PT Akbar Indo Makmur Stimec Tbk engages in coal general trading. It operates through the Sale and Purchase of Coal segments. The company was founded on May 7, 1997 and is headquartered in Jakarta Selatan, Indonesia.
IDX's Tactical Approach to Bitcoin & Managing Risk
Secara ini emiten mostly bergerak. AIMS Stock technical analysis analisis harian saham AIMS dilihat dari MA dan trendline sedang dalam kondisi dowentrand, tapi harga sudah tidak mampu membuat Lower low dan naik dan membentuk triangle. tunggu harga menembus triangle dan menembus area SnD diatas lalu bisa mengambil posisi buy.
How To Invest IDX Insights
By enabling diagnostic assessment in primary care settings, IDx aims to increase patient access to high-quality, affordable disease detection. The company's first product, IDx-DR, is an FDA.
IDX Investor AIMS Q4 2022 PT Akbar Indo Makmur Stimec Tbk Analisis Laporan Keuangan
By enabling diagnostic assessment in primary care settings, IDx aims to increase patient access to high-quality, affordable disease detection. The company's first product, LumineticsCore (formerly known as IDx-DR), is an FDA-cleared AI-based diagnostic system designed for use at the front lines of care to detect diabetic retinopathy.
IDX Announces Electronic Trading Platform for Securitized Products Business Wire
AIMS Indonesia Stock Exchange. AIMS Indonesia Stock Exchange. Market closed Market closed. No trades. See on Supercharts. Overview . Financials News Ideas Technicals . AIMS chart. Today −1.49% 5 days −12.58% 1 month −36.84% 6 months 103.70% Year to date −25.84% 1 year 77.42% 5 years 307.41% All time 560.00%.
IDX Recognized as a Category Leader in the 2022 Javelin Identity Protection Service Provider
PT Aims Indo Investama acquired 77.05% stake in PT. Akbar Indo Makmur Stimec Tbk (IDX:AIMS) from PT. Duta Invstama Nusantara for IDR 43 billion on November 23, 2017. The offer per share is IDR 253.43. PT Aims Indo Investama completed the acquisition of 77.05% stake in PT. Akbar Indo Makmur Stimec Tbk (IDX:AIMS) from PT.